期刊文献+

HPLC法同时测定人血浆中地尔硫卓及其代谢产物 被引量:4

Simultaneous Assay for Diltiazem and Deacetyldiltiazem in Human Plasma by HPLC
下载PDF
导出
摘要 本法用WatersBaseline810色谱工作站,Waters径向加压柱(Nova-PakC_(18)8mm×10cm,4μm),检测波长UV238nm,流动相为甲醇-水-二氯甲烷-0.1mol/L醋酸铵(64:23.5:2.5:10),流速:2.0ml/min;血样用混合溶剂一次提取,地尔硫和去乙酰地尔硫的提取回收率分别为85.2%、82.3%,平均方法回收率分别为99.6%、101.1%,最低检测浓度均为5ng/ml。 Diltiazem(DZ)is a benzothiazepine derivative with calcium-channel activity.It’s major metabolite is deacetyldiltiazem(DADZ)that showing pharmacological activity,The paper introduces a new HPLC methods for simultaneous quantitation of DZ and DADZ.Experiments were performed on Waters Baseline 810 HPLC system。A100mm × 8mm ID Waters radial compression modual(RCM)column was packed with 4μm Nova-Pak C_(18).The mobile phase was consisted of methanol-water-dichloromethane-0.1mol/L ammonium acetate solution(64:23.5:2.5:10)with the flow rate of 2.0ml/min,Haloperidoli was used as internal standard.1ml plasma sample was alkalinized with 0.5ml borate buffer(pH9.0)and 200ng of internal standard and 5ml of ether-n-butanol(95:5)were then added.The tubes were shaken for 3min and then centrifuged for 10min at 4000rlmin. The orgauic phase was transferred to another tubes,then vaporized by nitrogen. The residual reconstituted with 30μl of 5m mol/L H_2SO_4.20μl of the sample solution were injected for HPLC. The standard curves of plasma sample with linear range over the concentration 10~200ng/ml of DZ and DADZ,respectively were observed. The recoveries of DZ and DADZ were 99.6%and 10l.1%,respectively.Extraction efficiency of DZ and DADZ were 85.3%and 82.3%,respectively.
出处 《药物分析杂志》 CAS CSCD 北大核心 1995年第6期20-21,共2页 Chinese Journal of Pharmaceutical Analysis
关键词 地尔硫ZHUO 去乙酰 地尔硫Zuo HPLC diltiazem, deacetyldiltiazem,HPLC
  • 相关文献

同被引文献16

  • 1蒋娟娟,李一石,田蕾,黄一玲,成小如.控释和缓释地尔硫卓胶囊在健康人体的生物等效性[J].中国临床药理学杂志,2007,23(6):446-449. 被引量:3
  • 2[5]Alebie-Kolbah T,Plavsic F.Determination of serum diltiazem concentrations in a pharmacokinetic study using gas chromatography with electron capture detection[J].J Pharm Biomed Anal,1990;8:915-918.
  • 3[6]Hoglund P,Nilssun LG.Pharmaeokinetics of dihiazem and its metbolites after repeated multiple-dose treatments in healthy volunteers[J].Ther Drug Monit,1989;11:543-550.
  • 4[7]Scheiwe MW,Lankhaar G,Kleinbloesem CH.Bioequivalenee and relalive bioavailahility of a new diltiazem sustained release formulation[J].Arzneimittelforschun,1996;46:960-963.
  • 5[8]Christrup LL,Bonde J,Rasmussen SN,et al.Single-dose and steady-state pharmaeokinetics of diltiazem administered in two different tablet formulations[J].Pharmacol Toxicol,1992;71:305-307.
  • 6CHAFFMAN M,BROGDEN R N. Diltiazem: a re- view of its pharmacological properties and therapeutic efficacy [ J ]. Drugs, 1985,29 ( 5 ) : 387 - 454.
  • 7DASANDI B, SHAH S, SHIVPRAKASH. Develop- ment and validation of a high throughput and robust LC-MS/MS with electrospray ionization method for simultaneous quantitation of diltiazem and its two me- tabolites in human plasma:Application to a bioequiva- lence study[J]. J Chromatogr B, 2009, 877 ( 1 ) : 791 - 798.
  • 8MOLDEN E, HELEN BφE G, CHRISTENSEN H, et al. High-performance liquid chromatography-mass spectrometry analysis of diltiazem and 11 of its phase I metabolites in human plasma[J]. J Pharm Biomed Anal,2003,33(2):275 -285.
  • 9LI Jia-li, WANG Xue-ding, WANG Chang-xi, et al. Rapid and simultaneous determination of tacrolimus (FK506) and diltiazem in human whole blood by liq- uid chromatography-tandem mass spectrometry:Appli- cation to a clinical drug-drug interaction study [J ]. J Chromatogr B ,2008,867 ( 1 ) : 111 - 118.
  • 10FU Qiang, KANG K W, HAN H K. Repeated dosing of piperine induced gene expression of P-glycoprotein via stimulated pregnane-x-receptor activity and altered pharmacokinetics of diltiazem in rats[ J ]. Biopharm Drug Dispos ,2012,33 ( 8 ) :446 - 454.

引证文献4

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部